Masimo (NASDAQ:MASI) Releases FY25 Earnings Guidance

Masimo (NASDAQ:MASI) issued an update on its FY25 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $4.90-$5.10 for the period, compared to the consensus estimate of $4.74. Masimo also updated its FY 2024 guidance to 4.100-4.100 EPS.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Stifel Nicolaus reaffirmed a “buy” rating and set a $190.00 price objective (up from $170.00) on shares of Masimo in a research note on Friday, November 22nd. BTIG Research raised their price target on Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Raymond James boosted their price objective on Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research report on Friday, December 27th. Piper Sandler increased their price objective on Masimo from $180.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, December 18th. Finally, Wells Fargo & Company lifted their target price on shares of Masimo from $171.00 to $193.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 11th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, Masimo currently has a consensus rating of “Moderate Buy” and a consensus price target of $179.67.

Masimo Trading Down 1.2 %

NASDAQ MASI opened at $169.94 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. Masimo has a fifty-two week low of $101.61 and a fifty-two week high of $180.97. The stock has a market cap of $9.10 billion, a P/E ratio of 117.20 and a beta of 1.01. The stock has a 50 day simple moving average of $169.03 and a two-hundred day simple moving average of $139.75.

Masimo (NASDAQ:MASI) last announced its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.14. The company had revenue of $504.60 million during the quarter, compared to analyst estimates of $502.87 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The firm’s revenue was up 5.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.63 earnings per share. On average, analysts forecast that Masimo will post 4.03 earnings per share for the current year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.